Evidence-Based Minireview: Are DOACs an alternative to vitamin K antagonists for treatment of venous thromboembolism in patients with MPN?

Schieppati, F ;
Falanga, A

Department of Transfusion Medicine and Hematology, Hospital Papa Giovanni XXIII, Bergamo, Italy. Department of Medicine and Surgery, University of Milan Bicocca, Milan, Italy.

Hematology. American Society of Hematology. Education Program. 2021;(1):448-452

Full text from:

PubMed Central
Silverchair Information Systems

Methodological quality

Publication Type : Case Reports ; Review

Metadata

MeSH terms : Anticoagulants ; Factor Xa Inhibitors ; Myeloproliferative Disorders ; Vitamin K

Evidence-Based Minireview: Are DOACs an alternative to vitamin K antagonists for treatment of venous thromboembolism in patients with MPN?

Other resources

Methodological quality

Metadata